FDA 510(k) medical device database

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-25T06:40:13.662Z • Permanent link

Regulatory oversight in the medical device industry has taken a significant step forward with the unveiling of the FDA 510(k) medical device database. This comprehensive repository of medical device data has been years in the making, and its launch marks a major milestone in the FDA's efforts to enhance transparency and accountability in the industry. The database, which contains 176,140 records, is a testament to the FDA's commitment to protecting public health and promoting innovation in the medical device sector.

Dr. Janet Woodcock, the Commissioner of the FDA, has been a driving force behind the development of this database, which is expected to have a profound impact on the way medical device companies operate. "The FDA 510(k) medical device database is a critical tool for ensuring that medical devices are safe and effective before they are brought to market," Dr. Woodcock stated in a recent interview. "We are confident that this database will help us to identify and address any potential issues more quickly and efficiently, ultimately leading to better outcomes for patients." The database is expected to be a key component of the FDA's efforts to modernize its regulatory framework and reduce the burden on medical device companies.

The launch of the FDA 510(k) medical device database is also expected to have significant implications for the research community, with many experts hailing it as a major breakthrough in the field. Dr. Mark Mayeda, a leading researcher in the field of medical device innovation, noted that the database will provide researchers with a wealth of new data and insights, which will help to accelerate the development of new medical devices. "The FDA 510(k) medical device database is a game-changer for researchers and clinicians," Dr. Mayeda stated. "It will enable us to better understand the safety and efficacy of medical devices, and to identify areas for improvement. This will ultimately lead to better patient outcomes and more effective medical devices.

The launch of the FDA 510(k) medical device database is expected to have a significant impact on the medical device industry, with many companies already expressing enthusiasm for the new tool. Medtronic, a leading medical device manufacturer, has announced that it will be using the database to streamline its regulatory processes and reduce the time it takes to bring new products to market. "We are excited about the potential of the FDA 510(k) medical device database to enhance our regulatory processes and improve patient outcomes," said Dr. Jim Low, Medtronic's Vice President of Regulatory Affairs. "We believe that this database will help us to better understand the needs of patients and healthcare providers, and to develop medical devices that are more effective and safer.

The FDA 510(k) medical device database is also expected to have significant implications for the broader healthcare system, with many experts hailing it as a major step forward in the fight against medical device-related complications. The database will provide healthcare providers with a wealth of new data and insights, which will help them to better understand the safety and efficacy of medical devices. "The FDA 510(k) medical device database is a critical tool for healthcare providers," stated Dr. Robert Arntzen, a leading expert in medical device safety. "It will enable us to better understand the risks associated with medical devices, and to take steps to mitigate those risks. This will ultimately lead to better patient outcomes and a safer healthcare system.

The launch of the FDA 510(k) medical device database is part of a larger trend towards greater transparency and accountability in the medical device industry. In recent years, there have been a number of high-profile incidents involving medical devices, including the recall of the DePuy ASR hip replacement system and the deaths associated with the Johnson & Johnson talcum powder. These incidents have highlighted the need for greater regulatory oversight and transparency in the industry, and the FDA 510(k) medical device database is a major step forward in this regard.